FCCC LOGO Faculty Publications
Benson AB 3rd , Venook AP , Al-Hawary MM , Cederquist L , Chen YJ , Ciombor KK , Cohen S , Cooper HS , Deming D , Engstrom PF , Garrido-Laguna I , Grem JL , Grothey A , Hochster HS , Hoffe S , Hunt S , Kamel A , Kirilcuk N , Krishnamurthi S , Messersmith WA , Meyerhardt J , Miller ED , Mulcahy MF , Murphy JD , Nurkin S , Saltz L , Sharma S , Shibata D , Skibber JM , Sofocleous CT , Stoffel EM , Stotsky-Himelfarb E , Willett CG , Wuthrick E , Gregory KM , Freedman-Cass DA
NCCN Guidelines Insights: Colon Cancer, Version 2.2018
J Natl Compr Canc Netw. 2018 Apr;16(4) :359-369
PMID: 29632055   
Back to previous list
Abstract
The NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, perioperative treatment, surveillance, management of recurrent and metastatic disease, and survivorship. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel discussions for the 2018 update of the guidelines regarding risk stratification and adjuvant treatment for patients with stage III colon cancer, and treatment of BRAF V600E mutation-positive metastatic colorectal cancer with regimens containing vemurafenib.
Notes
1540-1413 Benson, Al B 3rd Venook, Alan P Al-Hawary, Mahmoud M Cederquist, Lynette Chen, Yi-Jen Ciombor, Kristen K Cohen, Stacey Cooper, Harry S Deming, Dustin Engstrom, Paul F Garrido-Laguna, Ignacio Grem, Jean L Grothey, Axel Hochster, Howard S Hoffe, Sarah Hunt, Steven Kamel, Ahmed Kirilcuk, Natalie Krishnamurthi, Smitha Messersmith, Wells A Meyerhardt, Jeffrey Miller, Eric D Mulcahy, Mary F Murphy, James D Nurkin, Steven Saltz, Leonard Sharma, Sunil Shibata, David Skibber, John M Sofocleous, Constantinos T Stoffel, Elena M Stotsky-Himelfarb, Eden Willett, Christopher G Wuthrick, Evan Gregory, Kristina M Freedman-Cass, Deborah A Journal Article United States J Natl Compr Canc Netw. 2018 Apr;16(4):359-369. doi: 10.6004/jnccn.2018.0021.